as of 01-28-2026 10:39am EST
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
| Founded: | 1997 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 159.7M | IPO Year: | 2018 |
| Target Price: | $110.00 | AVG Volume (30 days): | 23.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.23 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.02 - $75.00 | Next Earning Date: | 11-20-2025 |
| Revenue: | $18,970,000 | Revenue Growth: | 62.04% |
| Revenue Growth (this year): | 122.71% | Revenue Growth (next year): | -79.04% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
10% Owner
Avg Cost/Share
$42.98
Shares
198
Total Value
$8,510.04
Owned After
447,331
SEC Form 4
10% Owner
Avg Cost/Share
$41.92
Shares
2,394
Total Value
$100,347.86
Owned After
447,331
SEC Form 4
10% Owner
Avg Cost/Share
$41.99
Shares
22,497
Total Value
$944,743.52
Owned After
447,331
SEC Form 4
10% Owner
Avg Cost/Share
$41.99
Shares
35,169
Total Value
$1,476,626.74
Owned After
447,331
SEC Form 4
10% Owner
Avg Cost/Share
$41.85
Shares
8,638
Total Value
$361,533.99
Owned After
447,331
SEC Form 4
10% Owner
Avg Cost/Share
$41.68
Shares
1,626
Total Value
$67,764.53
Owned After
447,331
SEC Form 4
10% Owner
Avg Cost/Share
$41.66
Shares
260
Total Value
$10,832.46
Owned After
447,331
SEC Form 4
10% Owner
Avg Cost/Share
$41.15
Shares
1,019
Total Value
$41,935.62
Owned After
447,331
SEC Form 4
10% Owner
Avg Cost/Share
$40.37
Shares
2,735
Total Value
$110,412.22
Owned After
447,331
SEC Form 4
10% Owner
Avg Cost/Share
$40.00
Shares
87
Total Value
$3,480.00
Owned After
447,331
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | SLGL | 10% Owner | Jan 5, 2026 | Buy | $42.98 | 198 | $8,510.04 | 447,331 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Jan 2, 2026 | Buy | $41.92 | 2,394 | $100,347.86 | 447,331 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 31, 2025 | Buy | $41.99 | 22,497 | $944,743.52 | 447,331 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 30, 2025 | Buy | $41.99 | 35,169 | $1,476,626.74 | 447,331 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 29, 2025 | Buy | $41.85 | 8,638 | $361,533.99 | 447,331 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 26, 2025 | Buy | $41.68 | 1,626 | $67,764.53 | 447,331 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 23, 2025 | Buy | $41.66 | 260 | $10,832.46 | 447,331 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 22, 2025 | Buy | $41.15 | 1,019 | $41,935.62 | 447,331 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 17, 2025 | Buy | $40.37 | 2,735 | $110,412.22 | 447,331 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 12, 2025 | Buy | $40.00 | 87 | $3,480.00 | 447,331 |
See how SLGL stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "SLGL Sol-Gel Technologies Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.